Skip to content

Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

Maintenance of Anticoagulant and Antiplatelet Agents for Patients Undergoing Vitreoretinal Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01020656
Enrollment
206
Registered
2009-11-25
Start date
2009-01-31
Completion date
2009-06-30
Last updated
2009-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Detachment

Keywords

anticoagulant agents, antiplatelet agents, vitreoretinal surgery, Patients suffered from retinal detachment

Brief summary

Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Take or no anticoagulant treatment before surgery, * Vitreoretinal surgery

Exclusion criteria

none * No surgery * Anesthetic complication

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026